Influence of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro

European Journal of Haematology

Volumn 65, Issue 5, 2000, Pages 317-321

  Lech Maranda, Ewa ^a   Korycka, Anna ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

2 Chlorodeoxyadenosine; Cfu gm; Cultures in vitro; Gemcitabine; Interactions

Indexed keywords

CLADRIBINE; GEMCITABINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; STEM CELL;

ADOLESCENT; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CULTURE TECHNIQUES; CELL DIVISION; CLADRIBINE; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MIDDLE AGED; STEM CELLS;

EID: 0033736172     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.065005317.x     Document Type: Article

References (33)

1. Clinical and preclinical activity of 2'2'-difluorodeoxycytidine (gemcitabine)
2. Gemcitabine: Preclinical pharmacology and mechanism of action
3. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: Pharmacokinetic, pharmacodynamic, and molecular interactions
4. FLAG (fludarabine + cytosine arabinoside + G-CSF) induces complete remission in acute phase chronic myeloid leukemia: A case report
5. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-β-D-arabinofuranosyl-cytosine
6. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders
7. Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients
8. 2-Chlorodeoxyadenosine: Drug development priorities
9. Complete hematologic remission in chronic phase, Ph-chromosome positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine
10. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remissions in relapsed acute myeloid leukemia
11. Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low-grade non-Hodgkin lymphoma
12. Cladribine with cyclophosphamide and prednisone in management of low-grade lymphoproliferative malignancies
13. The influence of recombinant human tumor necrosis factor α and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro
14. The comparison of 2-CdA in combination with IFN-α or IFN-γ on CFU-GM and CFU-L in cultures in vitro
15. The interaction of gemcitabine and cytarabine on murine leukemias L1210 and P388 and on human normal and leukemic cell growth in vitro
16. Phase II study of gemcitabine in previously treated ovarian cancer patients
17. Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study
18. Phase I dose-escalation study of cisplatin in combination with gemcitabine in non-small cell lung cancer
19. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorode-oxyadenosine on murine leukemias L1210 and P388
20. Synthesis and cytotoxicity of deoxyadenosine analogues: Isomer distribution in the sodium salt glycosylation of 2,6-disubstituted purines
21. Erythroid colony formation in cultures of mouse and human bone marrow. Analysis of the requirement chromatography on agarose-concanavalin A
22. Inhibitory effect of 2-chlorodeoxyadenosine on granulocytic, erythroid and T-lymphocytic colony growth
23. Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine)
24. Interaction between cladribine (2-CdA) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myeloid leukemia
25. Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias
26. Effects of flud-arabine and gemcitabine on human acute myeloid leukemia cell line HL-60: Direct comparison of cytotoxicity and cellular Ara-C uptake enhancement
27. In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells
28. Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia
29. New chemotherapeutic agents in acute myeloid leukemia
30. Influence of 2-chlorodeoxy-adenosine alone and in combination with cytosine arabinoside on murine leukemias L1210 and P388
31. Gemcitabine: Metabolism, mechanism of action, and self-potentiation
32. Effect of deoxycitidine on 2-chlorodeoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells
33. Lack of cross-resistance with gemcitabine and cladribine in cladribine-resistant HL60 cells with elevated 5'-nucleosidase activity